Improving lung cancer screening in the Bronx

Implementation of a Centralized Screening Unit at Montefiore-Einstein

This study is trying to improve lung cancer screening for low-income people in the Bronx by setting up a special unit that helps patients get screened and follow up on their care.

Quick facts

• Phase: NA
• Study type: Interventional
• Enrollment: 9460 (estimated)
• Ages: 50 Years to 77 Years
• Sex: All
• Sponsor: Albert Einstein College of Medicine (other)
• Locations: 1 site (The Bronx, New York)
• Trial ID: NCT06284408 on ClinicalTrials.gov

What this trial studies

This initiative aims to enhance lung cancer screening rates in the Bronx, New York, by establishing a Centralized Screening Unit (CSU). The CSU will streamline the workflow for lung cancer screening, addressing barriers such as incomplete smoking histories and lack of patient navigation. By shifting responsibilities away from busy clinical practices, the CSU will provide comprehensive support services to eligible patients, thereby increasing adherence to screening guidelines and follow-up care. The study focuses on a low-income, predominantly Hispanic and Black population, where lung cancer screening uptake has been particularly low.

Who should consider this trial

Good fit: Ideal candidates are individuals aged 50-77 who are past or current smokers with a significant smoking history and no recent chest CT scans.

Not a fit: Patients who are instructed by their primary care provider not to be contacted or who do not meet the eligibility criteria will not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could significantly increase lung cancer screening rates and reduce mortality in underserved communities.

How similar studies have performed: Other studies have shown that centralized approaches to cancer screening can improve adherence and outcomes, suggesting this method may be effective.

Eligibility criteria

Inclusion Criteria:

Clinic level:

* a NYC RING affiliated clinic,
* Opt into and agree to research protocol;

Patient level:

* Age 50-77 for participants,
* past or current smoker,
* 20+ pack-years tobacco,
* has quit smoking within the last 15 years,
* without chest CT within the past 12 months, and,
* no history of lung cancer or and at least 5 years since the diagnosis of any other malignancy

Exclusion Criteria:

Clinic level:

* only treats pediatric patients,
* Opt out of research protocol;

Patient level:

* Primary care provider instruction to not contact an individual for any reason. Any individual inadvertently contacted who does not meet these criteria will be excluded from the study.

Where this trial is running

The Bronx, New York

• Montefiore Medical Center's New York City Research and Improvement Networking Group (NYC RING) — The Bronx, New York, United States (RECRUITING)

Study contacts

• Principal investigator: H. Dean Hosgood, PhD — Albert Einstein College of Medicine
• Study coordinator: H. Dean Hosgood, PhD

Conditions: Lung Cancer, Lung Cancer Screening, Low dose computed tomography, Centralized Screening Unit